Estimation of benefits, harms, and resource requirements of riskbased screening approaches
Summary
MISCAN and EU-TOPIA models will be used to estimate additional harms, benefits and costs of risk-based screening approaches compared to existing uniform screening approaches by region of Europe.
This task will be led by EMC, Netherlands, co-led by UMIT, Austria.
Subscribe to our newsletter to get news and updates.
Subscribe to our newsletter to get news and updates.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959